NovaRad has recently received U.S. Food and Drug Administration (FDA)clearance for reading and interpreting mammography studies for its NovaPACS which is used for the distribution and viewing of mammography studies, including window,level,zoom and volumetric measurements.
If you enjoy this content, please share it with a colleague
Related Content
April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...
April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...
March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...
March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...
March 12, 2024 — Konica Minolta Healthcare Americas, Inc. announced today the new integration of the Exa Platform with ...
March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...
February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...
February 20, 2024 —FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...
February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...